Scope Fluidics Spolka Akcyjna (WAR:SCP) GF Value Rank: 9 (As of Jul. 29, 2026) — 350% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:SCP Scope Fluidics Spolka Akcyjna WAR:SCP
45 GF Score
Price zł117.20
GF Value zł127.86
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Scope Fluidics Spolka Akcyjna GF Value Rank?

Scope Fluidics Spolka Akcyjna WAR:SCP -0.85% 45 GF Value Rank is 9 as of Jul. 29, 2026, which is 350% above its 10-year median of 2.00. GuruFocus rates WAR:SCP with a GF Score™ of 45/100 and a GF Value™ of zł127.86 (Fairly Valued). The stock has 4 warning signs investors should review.

Scope Fluidics Spolka Akcyjna has the GF Value Rank of 9.

GF Value Rank evaluates the exclusive GuruFocus valuation and performance of a stock, rated on a scale from 1 to 10. It is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

A higher score indicates a stock with a relatively low valuation and substantial potential for outperformance. Conversely, a lower score often reflects stocks that are either highly overvalued or deeply undervalued, both of which tend to underperform.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.


Scope Fluidics Spolka Akcyjna GF Value Rank Related Terms


WAR:SCP vs TMO, DHR, IDXX: GF Value Rank Comparison

For the Diagnostics & Research subindustry, Scope Fluidics Spolka Akcyjna's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scope Fluidics Spolka Akcyjna GF Value Rank vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Scope Fluidics Spolka Akcyjna's GF Value Rank distribution charts can be found below:

* The bar in red indicates where Scope Fluidics Spolka Akcyjna's GF Value Rank falls into.


WAR:SCP
45GF Score
Scope Fluidics Spolka Akcyjna WAR:SCP
GF Value Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Value Rank →
What does a GF Value Rank of 9 mean?
Scope Fluidics Spolka Akcyjna (WAR:SCP) has a GF Value Rank of 9 as of Jul. 29, 2026. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on Scope Fluidics Spolka Akcyjna and its competitors. This is 350% above median its historical median of 2.00. Over the past decade, Scope Fluidics Spolka Akcyjna's GF Value Rank has ranged from 1.00 to 9.00.
Is Scope Fluidics Spolka Akcyjna's GF Value Rank too high?
Scope Fluidics Spolka Akcyjna's current GF Value Rank of 9 is 350% above median its 10-year median of 2.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 9.00. Overall, Scope Fluidics Spolka Akcyjna has a GF Score™ of 45/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Scope Fluidics Spolka Akcyjna's GF Value Rank compare to TMO and DHR?
Scope Fluidics Spolka Akcyjna's GF Value Rank of 9 can be compared against companies in the Medical Diagnostics & Research industry. Historically, Scope Fluidics Spolka Akcyjna's own GF Value Rank has ranged from 1.00 to 9.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Value Rank for a Medical Diagnostics & Research company?
A good GF Value Rank depends on the Medical Diagnostics & Research industry context. However, GF Value Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Value Rank mean?
A high GF Value Rank can signal that a stock is expensive relative to its fundamentals. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on Scope Fluidics Spolka Akcyjna and its competitors. Scope Fluidics Spolka Akcyjna's current GF Value Rank is 9, which is 350% above median its own 10-year median of 2.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scope Fluidics Spolka Akcyjna stock overvalued right now?
Based on GuruFocus' analysis, Scope Fluidics Spolka Akcyjna (WAR:SCP) is currently considered Fairly Valued. The stock's GF Value™ is zł127.86, compared to a current price of zł117.20 — trading 8.3% below its estimated fair value. The current GF Value Rank is 9, which is 350% above median its 10-year median of 2.00. Scope Fluidics Spolka Akcyjna's overall GF Score™ is 45/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Value Rank calculated?
GF Value Rank is calculated from a company's financial statements. For Scope Fluidics Spolka Akcyjna (WAR:SCP), the current GF Value Rank is 9 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Scope Fluidics Spolka Akcyjna (WAR:SCP) Overvalued in 2026?

Based on GuruFocus' analysis, Scope Fluidics Spolka Akcyjna stock appears to be undervalued. The current stock price of zł117.20 is trading 8.3% below its estimated GF Value™ of zł127.86. GuruFocus considers Scope Fluidics Spolka Akcyjna to be Fairly Valued.

Key valuation signals for WAR:SCP:

  • GF Value Rank: 9 (350% above median its 10-year median of 2.00)
  • GF Value™: zł127.86 vs. price of zł117.20 (8.3% below fair value)
  • GF Score™: 45/100 with 4 warning signs

No single metric tells the full story. See the WAR:SCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Scope Fluidics Spolka Akcyjna Business Description

Other Exchanges S84:Germany
Address Duchnicka 3, Build 16, Entrance A, Warsaw, POL, 01-796
Scope Fluidics Spolka Akcyjna focuses on global challenges in health to develop diagnostic and med tech solutions. The company combines the expertise in microfluidic technology with the awareness of the challenges in medical diagnostics. It provides prototyping support for diagnostic services.
45GF Score

Get the complete analysis for WAR:SCP

GF Value Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł117.20
Price
zł127.86
GF Value